US EditionCentury Therapeutics to Present Preclinical Data at EULAR 2025 Congress
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced its participation in the upcoming European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, set to take place from June 11-14 at Fira de Barcelona in Spain. The company will present new data highlighting progress in its preclinical cell therapy pipeline and investigative programs targeting autoimmune diseases and cancer. The presentations will showcase Cen…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
